177 related articles for article (PubMed ID: 29678521)
21. The role of aldehyde oxidase in drug metabolism.
Garattini E; Terao M
Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):487-503. PubMed ID: 22335465
[TBL] [Abstract][Full Text] [Related]
22. Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidase.
Choughule KV; Joswig-Jones CA; Jones JP
Biochem Pharmacol; 2015 Aug; 96(3):288-95. PubMed ID: 26032640
[TBL] [Abstract][Full Text] [Related]
23. Enzymatic oxidation of phthalazine with guinea pig liver aldehyde oxidase and liver slices: inhibition by isovanillin.
Panoutsopoulos GI; Beedham C
Acta Biochim Pol; 2004; 51(4):943-51. PubMed ID: 15625566
[TBL] [Abstract][Full Text] [Related]
24. Aldehyde oxidase at the crossroad of metabolism and preclinical screening.
Cheshmazar N; Dastmalchi S; Terao M; Garattini E; Hamzeh-Mivehroud M
Drug Metab Rev; 2019 Nov; 51(4):428-452. PubMed ID: 31549868
[TBL] [Abstract][Full Text] [Related]
25. 1-substituted phthalazines as probes of the substrate-binding site of mammalian molybdenum hydroxylases.
Beedham C; Bruce SE; Critchley DJ; Rance DJ
Biochem Pharmacol; 1990 Apr; 39(7):1213-21. PubMed ID: 2322306
[TBL] [Abstract][Full Text] [Related]
26. Identification of aldehyde oxidase 1 and aldehyde oxidase homologue 1 as dioxin-inducible genes.
Rivera SP; Choi HH; Chapman B; Whitekus MJ; Terao M; Garattini E; Hankinson O
Toxicology; 2005 Feb; 207(3):401-9. PubMed ID: 15664268
[TBL] [Abstract][Full Text] [Related]
27. A comprehensive review of in silico approaches for the prediction and modulation of aldehyde oxidase-mediated drug metabolism: The current features, challenges and future perspectives.
Soltani S; Hallaj-Nezhadi S; Rashidi MR
Eur J Med Chem; 2021 Oct; 222():113559. PubMed ID: 34119831
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine.
Barnes JP; Yang SM; Thompson TS; Guevarra CM; Pleasant SS; Do TQ; Crouch RD
Drug Metab Dispos; 2023 Jun; 51(6):782-791. PubMed ID: 36921993
[TBL] [Abstract][Full Text] [Related]
29. Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions.
Nirogi R; Kandikere V; Palacharla RC; Bhyrapuneni G; Kanamarlapudi VB; Ponnamaneni RK; Manoharan AK
Xenobiotica; 2014 Mar; 44(3):197-204. PubMed ID: 24156774
[TBL] [Abstract][Full Text] [Related]
30. Aldehyde oxidase 1 activity and protein expression in human, rabbit, and pig ocular tissues.
Hammid A; Fallon JK; Vellonen KS; Lassila T; Reinisalo M; Urtti A; Gonzalez F; Tolonen A; Smith PC; Honkakoski P
Eur J Pharm Sci; 2023 Dec; 191():106603. PubMed ID: 37827455
[TBL] [Abstract][Full Text] [Related]
31. Evolution, expression, and substrate specificities of aldehyde oxidase enzymes in eukaryotes.
Terao M; Garattini E; Romão MJ; Leimkühler S
J Biol Chem; 2020 Apr; 295(16):5377-5389. PubMed ID: 32144208
[TBL] [Abstract][Full Text] [Related]
32. Aldehyde oxidase mediated drug metabolism: an underpredicted obstacle in drug discovery and development.
Gajula SNR; Nathani TN; Patil RM; Talari S; Sonti R
Drug Metab Rev; 2022 Nov; 54(4):427-448. PubMed ID: 36369949
[TBL] [Abstract][Full Text] [Related]
33. Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver.
Kitamura S; Sugihara K
Xenobiotica; 2014 Jan; 44(2):123-34. PubMed ID: 24329499
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase.
Lake BG; Ball SE; Kao J; Renwick AB; Price RJ; Scatina JA
Xenobiotica; 2002 Oct; 32(10):835-47. PubMed ID: 12419014
[TBL] [Abstract][Full Text] [Related]
35. Aldehyde oxidase activity and inhibition in hepatocytes and cytosolic fractions from mouse, rat, monkey and human.
Sahi J; Khan KK; Black CB
Drug Metab Lett; 2008 Aug; 2(3):176-83. PubMed ID: 19356090
[TBL] [Abstract][Full Text] [Related]
36. Time Course of Aldehyde Oxidase and Why It Is Nonlinear.
Abbasi A; Paragas EM; Joswig-Jones CA; Rodgers JT; Jones JP
Drug Metab Dispos; 2019 May; 47(5):473-483. PubMed ID: 30787100
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of guinea pig aldehyde oxidase activity by different flavonoid compounds: An in vitro study.
Siah M; Farzaei MH; Ashrafi-Kooshk MR; Adibi H; Arab SS; Rashidi MR; Khodarahmi R
Bioorg Chem; 2016 Feb; 64():74-84. PubMed ID: 26722818
[TBL] [Abstract][Full Text] [Related]
38. The two faces of aldehyde oxidase: Oxidative and reductive transformations of 5-nitroquinoline.
Paragas EM; Humphreys SC; Min J; Joswig-Jones CA; Jones JP
Biochem Pharmacol; 2017 Dec; 145():210-217. PubMed ID: 28888950
[TBL] [Abstract][Full Text] [Related]
39. Oxidative metabolism and pharmacokinetics of the EGFR inhibitor BIBX1382 in chimeric NOG-TKm30 mice transplanted with human hepatocytes.
Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
Drug Metab Pharmacokinet; 2021 Dec; 41():100419. PubMed ID: 34624627
[TBL] [Abstract][Full Text] [Related]
40. Quantitative study of the structural requirements of phthalazine/quinazoline derivatives for interaction with human liver aldehyde oxidase.
Ghafourian T; Rashidi MR
Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1066-71. PubMed ID: 11558587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
